Request for Covid-19 Impact Assessment of this Report
The United States CAR-T Cellular Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CAR-T Cellular Immunotherapy market, reaching US$ million by the year 2028. As for the Europe CAR-T Cellular Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main CAR-T Cellular Immunotherapy players cover Fosun Kite Biotechnology, Gilead Sciences, Novartis, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cellular Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Allogeneic
Autologous
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Fosun Kite Biotechnology
Gilead Sciences
Novartis
Bristol-Myers Squibb
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CAR-T Cellular Immunotherapy Market Size 2017-2028
2.1.2 CAR-T Cellular Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CAR-T Cellular Immunotherapy Segment by Type
2.2.1 Allogeneic
2.2.2 Autologous
2.3 CAR-T Cellular Immunotherapy Market Size by Type
2.3.1 CAR-T Cellular Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CAR-T Cellular Immunotherapy Market Size Market Share by Type (2017-2022)
2.4 CAR-T Cellular Immunotherapy Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 CAR-T Cellular Immunotherapy Market Size by Application
2.5.1 CAR-T Cellular Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CAR-T Cellular Immunotherapy Market Size Market Share by Application (2017-2022)
3 CAR-T Cellular Immunotherapy Market Size by Player
3.1 CAR-T Cellular Immunotherapy Market Size Market Share by Players
3.1.1 Global CAR-T Cellular Immunotherapy Revenue by Players (2020-2022)
3.1.2 Global CAR-T Cellular Immunotherapy Revenue Market Share by Players (2020-2022)
3.2 Global CAR-T Cellular Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T Cellular Immunotherapy by Regions
4.1 CAR-T Cellular Immunotherapy Market Size by Regions (2017-2022)
4.2 Americas CAR-T Cellular Immunotherapy Market Size Growth (2017-2022)
4.3 APAC CAR-T Cellular Immunotherapy Market Size Growth (2017-2022)
4.4 Europe CAR-T Cellular Immunotherapy Market Size Growth (2017-2022)
4.5 Middle East & Africa CAR-T Cellular Immunotherapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas CAR-T Cellular Immunotherapy Market Size by Country (2017-2022)
5.2 Americas CAR-T Cellular Immunotherapy Market Size by Type (2017-2022)
5.3 Americas CAR-T Cellular Immunotherapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Cellular Immunotherapy Market Size by Region (2017-2022)
6.2 APAC CAR-T Cellular Immunotherapy Market Size by Type (2017-2022)
6.3 APAC CAR-T Cellular Immunotherapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CAR-T Cellular Immunotherapy by Country (2017-2022)
7.2 Europe CAR-T Cellular Immunotherapy Market Size by Type (2017-2022)
7.3 Europe CAR-T Cellular Immunotherapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CAR-T Cellular Immunotherapy by Region (2017-2022)
8.2 Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Type (2017-2022)
8.3 Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CAR-T Cellular Immunotherapy Market Forecast
10.1 Global CAR-T Cellular Immunotherapy Forecast by Regions (2023-2028)
10.1.1 Global CAR-T Cellular Immunotherapy Forecast by Regions (2023-2028)
10.1.2 Americas CAR-T Cellular Immunotherapy Forecast
10.1.3 APAC CAR-T Cellular Immunotherapy Forecast
10.1.4 Europe CAR-T Cellular Immunotherapy Forecast
10.1.5 Middle East & Africa CAR-T Cellular Immunotherapy Forecast
10.2 Americas CAR-T Cellular Immunotherapy Forecast by Country (2023-2028)
10.2.1 United States CAR-T Cellular Immunotherapy Market Forecast
10.2.2 Canada CAR-T Cellular Immunotherapy Market Forecast
10.2.3 Mexico CAR-T Cellular Immunotherapy Market Forecast
10.2.4 Brazil CAR-T Cellular Immunotherapy Market Forecast
10.3 APAC CAR-T Cellular Immunotherapy Forecast by Region (2023-2028)
10.3.1 China CAR-T Cellular Immunotherapy Market Forecast
10.3.2 Japan CAR-T Cellular Immunotherapy Market Forecast
10.3.3 Korea CAR-T Cellular Immunotherapy Market Forecast
10.3.4 Southeast Asia CAR-T Cellular Immunotherapy Market Forecast
10.3.5 India CAR-T Cellular Immunotherapy Market Forecast
10.3.6 Australia CAR-T Cellular Immunotherapy Market Forecast
10.4 Europe CAR-T Cellular Immunotherapy Forecast by Country (2023-2028)
10.4.1 Germany CAR-T Cellular Immunotherapy Market Forecast
10.4.2 France CAR-T Cellular Immunotherapy Market Forecast
10.4.3 UK CAR-T Cellular Immunotherapy Market Forecast
10.4.4 Italy CAR-T Cellular Immunotherapy Market Forecast
10.4.5 Russia CAR-T Cellular Immunotherapy Market Forecast
10.5 Middle East & Africa CAR-T Cellular Immunotherapy Forecast by Region (2023-2028)
10.5.1 Egypt CAR-T Cellular Immunotherapy Market Forecast
10.5.2 South Africa CAR-T Cellular Immunotherapy Market Forecast
10.5.3 Israel CAR-T Cellular Immunotherapy Market Forecast
10.5.4 Turkey CAR-T Cellular Immunotherapy Market Forecast
10.5.5 GCC Countries CAR-T Cellular Immunotherapy Market Forecast
10.6 Global CAR-T Cellular Immunotherapy Forecast by Type (2023-2028)
10.7 Global CAR-T Cellular Immunotherapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Fosun Kite Biotechnology
11.1.1 Fosun Kite Biotechnology Company Information
11.1.2 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product Offered
11.1.3 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Fosun Kite Biotechnology Main Business Overview
11.1.5 Fosun Kite Biotechnology Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR-T Cellular Immunotherapy Product Offered
11.2.3 Gilead Sciences CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis CAR-T Cellular Immunotherapy Product Offered
11.3.3 Novartis CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product Offered
11.4.3 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
12 Research Findings and Conclusion
Table 1. CAR-T Cellular Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Allogeneic
Table 3. Major Players of Autologous
Table 4. CAR-T Cellular Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global CAR-T Cellular Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global CAR-T Cellular Immunotherapy Market Size Market Share by Type (2017-2022)
Table 7. CAR-T Cellular Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global CAR-T Cellular Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global CAR-T Cellular Immunotherapy Market Size Market Share by Application (2017-2022)
Table 10. Global CAR-T Cellular Immunotherapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global CAR-T Cellular Immunotherapy Revenue Market Share by Player (2020-2022)
Table 12. CAR-T Cellular Immunotherapy Key Players Head office and Products Offered
Table 13. CAR-T Cellular Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CAR-T Cellular Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global CAR-T Cellular Immunotherapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas CAR-T Cellular Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Country (2017-2022)
Table 20. Americas CAR-T Cellular Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Type (2017-2022)
Table 22. Americas CAR-T Cellular Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Application (2017-2022)
Table 24. APAC CAR-T Cellular Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Region (2017-2022)
Table 26. APAC CAR-T Cellular Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Type (2017-2022)
Table 28. APAC CAR-T Cellular Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Application (2017-2022)
Table 30. Europe CAR-T Cellular Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Country (2017-2022)
Table 32. Europe CAR-T Cellular Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Type (2017-2022)
Table 34. Europe CAR-T Cellular Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of CAR-T Cellular Immunotherapy
Table 43. Key Market Challenges & Risks of CAR-T Cellular Immunotherapy
Table 44. Key Industry Trends of CAR-T Cellular Immunotherapy
Table 45. Global CAR-T Cellular Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global CAR-T Cellular Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global CAR-T Cellular Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global CAR-T Cellular Immunotherapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global CAR-T Cellular Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global CAR-T Cellular Immunotherapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. Fosun Kite Biotechnology Details, Company Type, CAR-T Cellular Immunotherapy Area Served and Its Competitors
Table 52. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product Offered
Table 53. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Fosun Kite Biotechnology Main Business
Table 55. Fosun Kite Biotechnology Latest Developments
Table 56. Gilead Sciences Details, Company Type, CAR-T Cellular Immunotherapy Area Served and Its Competitors
Table 57. Gilead Sciences CAR-T Cellular Immunotherapy Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences CAR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Gilead Sciences Latest Developments
Table 61. Novartis Details, Company Type, CAR-T Cellular Immunotherapy Area Served and Its Competitors
Table 62. Novartis CAR-T Cellular Immunotherapy Product Offered
Table 63. Novartis Main Business
Table 64. Novartis CAR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Novartis Latest Developments
Table 66. Bristol-Myers Squibb Details, Company Type, CAR-T Cellular Immunotherapy Area Served and Its Competitors
Table 67. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product Offered
Table 68. Bristol-Myers Squibb Main Business
Table 69. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Bristol-Myers Squibb Latest Developments
List of Figures
Figure 1. CAR-T Cellular Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Cellular Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CAR-T Cellular Immunotherapy Market Size Market Share by Type in 2021
Figure 7. CAR-T Cellular Immunotherapy in Hospital
Figure 8. Global CAR-T Cellular Immunotherapy Market: Hospital (2017-2022) & ($ Millions)
Figure 9. CAR-T Cellular Immunotherapy in Pharmacy
Figure 10. Global CAR-T Cellular Immunotherapy Market: Pharmacy (2017-2022) & ($ Millions)
Figure 11. CAR-T Cellular Immunotherapy in Other
Figure 12. Global CAR-T Cellular Immunotherapy Market: Other (2017-2022) & ($ Millions)
Figure 13. Global CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2021
Figure 14. Global CAR-T Cellular Immunotherapy Revenue Market Share by Player in 2021
Figure 15. Global CAR-T Cellular Immunotherapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas CAR-T Cellular Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC CAR-T Cellular Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe CAR-T Cellular Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa CAR-T Cellular Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas CAR-T Cellular Immunotherapy Value Market Share by Country in 2021
Figure 21. Americas CAR-T Cellular Immunotherapy Consumption Market Share by Type in 2021
Figure 22. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2021
Figure 23. United States CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Region in 2021
Figure 28. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2021
Figure 29. China CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Country in 2021
Figure 36. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Type in 2021
Figure 37. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2021
Figure 38. Germany CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2021
Figure 46. Egypt CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country CAR-T Cellular Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 55. United States CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 59. China CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 63. India CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 66. France CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 67. UK CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries CAR-T Cellular Immunotherapy Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...